Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-05-15 00:00:00 ET · period of report 2024-05-13 · accession 0001127602-24-015442 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-15 | 2024-05-14 | TMO | Williamson Stephen | SVP, CFO | G - Gift | $0.00 | -16.0K | 20.5K | -44% | $0 |
| DI | 2024-05-15 | 2024-05-14 | TMO | Williamson Stephen | SVP, CFO | G - Gift | $0.00 | +12.7K | 12.7K | New | $0 |
| D | 2024-05-15 | 2024-05-13 | TMO | Williamson Stephen | SVP, CFO | S - Sale+OE | $591.27 | -21.9K | 36.5K | -38% | -$12.96M |
| D | 2024-05-15 | 2024-05-13 | TMO | Williamson Stephen | SVP, CFO | M - OptEx | $210.68 | +21.9K | 58.4K | +60% | +$4.62M |
| D | 2024-05-15 | 2024-05-13 | TMO | Williamson Stephen | SVP, CFO | M - OptEx | $0.00 | -21.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-14 | G | D | 3,297 | $0.00 | 33,184.99 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-14 | G | A | 12,674 | $0.00 | 12,674 | I | — | — | |
| 3 | Common | Common Stock | 2024-05-14 | G | D | 12,674 | $0.00 | 20,510.99 | D | — | — | |
| 4 | Common | Common Stock | 2024-05-13 | S | D | 21,925 | $591.27 | 36,481.99 | D | — | — | |
| 5 | Common | Common Stock | 2024-05-13 | M | A | 21,925 | $210.68 | 58,406.99 | D By SLAT | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-05-13 | M | D | 21,925 | $0.00 | 0 | D | $210.68 · — to 2025-02-27 | 21,925 Common Stock | (F3) The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022. |